Clinical Trial: A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Study Status: Completed
Recruit Status: RECRUITING
Condition: Relapsed or Refractory Acute Myeloid Leukemia
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label, Safety, Tolerability, And Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Brief Summary:
This is an open-label, non-randomized, Phase 1 study to determine the safety and tolerability of NC525.This study will also assess the clinical benefit in subjects with advanced myeloid neoplasms.
Read more